[New aminoglycoside desoxystreptamine-containing antibiotics].
D000583:Amikacin / Q000494:pharmacology; D000617:Aminoglycosides / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity; D002076:Butirosin Sulfate / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000031:analogs & derivatives / Q000494:pharmacology; D006595:Hexosamines / Q000494:pharmacology*; D007928:Lethal Dose 50; D008826:Microbial Sensitivity Tests; D008968:Molecular Conformation; D010303:Paromomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D012271:Ribostamycin / Q000494:pharmacology; D012853:Sisomicin / Q000031:analogs & derivatives / Q000494:pharmacology; D014031:Tobramycin / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D006595:Hexosamines; D012271:Ribostamycin; D002076:Butirosin Sulfate; D010303:Paromomycin; D000583:Amikacin; D014031:Tobramycin; D012853:Sisomicin
Novye aminoglikozidnye dezoksistreptaminsoderzhashchie antibiotiki